Sara Sigler
Family · Groveport, OHNPI 1770968091
Payments from drug & device makers
Across 223 payments — averaging $14.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$794
- Novo Nordisk$520
- Pfizer$190
- Lilly USA, LLC$178
- Bayer$169
- Merck$128
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,307100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 75 | $794 |
| Novo Nordisk | 35 | $520 |
| Pfizer | 11 | $190 |
| Lilly USA, LLC | 11 | $178 |
| Bayer | 8 | $169 |
| Merck | 8 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $126 |
| AstraZeneca | 8 | $110 |
| Teva Pharmaceuticals USA, Inc. | 5 | $110 |
| Abbott | 5 | $94 |
| GSK | 6 | $81 |
| Medtronic | 3 | $78 |
| Boehringer Ingelheim | 5 | $75 |
| Amgen | 4 | $72 |
| Exact Sciences | 3 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| Astellas Pharma US Inc | 3 | $54 |
| Lucid Diagnostics Inc. | 3 | $51 |
| Vertex | 2 | $41 |
| Grifols USA, LLC | 2 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Johnson & Johnson | 2 | $24 |
| Viiv Healthcare Company | 1 | $23 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$3,307 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 76 | $898 |
| Omeprazole | 62 | $632 |
| Montelukast Sodium | 30 | $596 |
| Levothyroxine Sodium | 64 | $505 |
| Simvastatin | 31 | $429 |
| Losartan Potassium | 39 | $423 |
| Metformin Hcl ErMetformin Hcl | 20 | $421 |
| Gabapentin | 13 | $323 |
| Lisinopril | 53 | $295 |
| Potassium Chloride | 11 | $277 |
| Tamsulosin Hcl | 13 | $259 |
| Metoprolol Succinate | 23 | $257 |
| Ezetimibe | 13 | $242 |
| Amlodipine Besylate | 55 | $234 |
| Pravastatin Sodium | 14 | $207 |
Paid to pharmacies, not to this prescriber.
Other family in Groveport
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.